Acquires BASF's Food & Health Ingredients BusinessLouis Dreyfus Co Acquires BASF's Food & Health Ingredients BusinessThe acquisition also includes a production site and state-of-the-art R&D center in Illertissen and three application labs outside of Germany BASF has signed a binding agreement to sell its Food and Health Performance Ingredients business including the production site in Illertissen a leading global merchant and processor of agricultural goods including high-quality BASF’s Food and Health Performance Ingredients business includes food performance ingredients such as aeration and whipping agents food emulsifiers and fat powder grades; health ingredients such as plant sterols esters omega-3 oils for human nutrition and some smaller product lines LDC aims to leverage its existing strengths in oils and fats to reinforce its global position in nutritional and functional ingredients “In line with our strategic plans for revenue diversification through more value-added products and growth in downstream markets this agreement is an opportunity to accelerate LDC’s participation in the rapidly growing plant-based ingredients market,” said Michael Gelchie “We are excited about the prospect of this transaction as LDC’s first investment in dedicated facilities to produce food and health performance ingredients at scale.”     Related:Conagra Brands to Sell Chef Boyardee for $600M “Building on our teams’ success to develop this business very well over the last years LDC as a future-oriented company can offer our employees and portfolio a promising perspective,” said Michael Heinz member of the Board of Executive Directors of BASF and responsible for the Nutrition & Health division “The divestment of this business to LDC supports our strategic portfolio optimization and will allow us to focus on our core businesses in Nutrition & Health We remain committed to leveraging our core product platforms and expanding our business in key areas such as vitamins approximately 300 employees are expected to transfer from BASF to LDC as of the closing of the transaction Kristen also worked in television as the digital producer helping write scripts for advertiser spots and other consumer magazines owned by Petersen Publishing and Weider Publishing She also worked at a Microsoft partner magazine Redmond (formerly Microsoft Professional magazine) as the associate editor Kristen worked as the editorial assistant for a regional weekly newspaper while earning her B.A in journalism with a concentration in public relations from Central Michigan University Conagra Brands to Sell Chef Boyardee for $600M This website is using a security service to protect itself from online attacks The action you just performed triggered the security solution There are several actions that could trigger this block including submitting a certain word or phrase You can email the site owner to let them know you were blocked Please include what you were doing when this page came up and the Cloudflare Ray ID found at the bottom of this page In response to the regulations around the world (including EU Green Deal) aiming to promote safer and more sustainable chemicals into the environment, BASF is introducing its first readily biodegradable dispersant to the agrochemical market: Sokalan® CP 301 Dispersants are essential additives in agricultural formulations ensuring the homogenous distribution of active ingredients and enhancing formulation stability non-biodegradable additives can persist in the environment once sprayed on the field The market anticipates stricter regulations for such additives soon Biodegradable dispersants exhibiting high performance in the formulation remain limited due to biodegradability often resulting in decreasing storage stability of the formulation “Leveraging the expertise of our chemists and application specialists we have successfully identified an excellent dispersant that meets biodegradability criteria in sludge and soil while demonstrating exceptional performance in dispersing challenging active ingredients and maintaining storage stability,” says Laszlo Szarvas Vice President – Head of Research & Development Industrial & Institutional Cleaning and Industrial Formulators BASF | Nunhems adds 5 ToBRFV-resistant varieties Sokalan® CP 301 addresses a market gap for sustainable agriculture by offering a readily biodegradable alternative to existing dispersants. “With this, we are enabling the green transformation of our customers by further building on our excellent track record in innovation,” states Jordi Tormo, Vice President, Industrial Formulators Business Management, EMEA. This launch underscores BASF´s dedication to sustainable additives. Sokalan® CP 301 sets new standards in environmental responsibility and chemical innovation. Every Wednesday in your email Inbox, get the highlights of the horticultural week This website is using a security service to protect itself from online attacks. The action you just performed triggered the security solution. There are several actions that could trigger this block including submitting a certain word or phrase, a SQL command or malformed data. You can email the site owner to let them know you were blocked. Please include what you were doing when this page came up and the Cloudflare Ray ID found at the bottom of this page. 04 Apr 2025 17:00:00 GMT?.css-1txiau5-AnswerContainer{color:var(--GlobalColorScheme-Text-secondaryText2);}FV Illertissen vs TSV Schwaben Augsburg on Fri Predicted lineups are available for the match a few days in advance while the actual lineup will be available about an hour ahead of the match The current head to head record for the teams are FV Illertissen 1 win(s) Have scored 8 goals in their last 5 matches Who won between FV Illertissen and TSV Schwaben Augsburg on Fri 04 Apr 2025 17:00:00 GMT?FV Illertissen vs TSV Schwaben Augsburg on Fri 04 Apr 2025 17:00:00 GMT ended in a 1–1 tie.InsightsHave scored 6 goals in their last 5 matches FV Illertissen is playing home against TSV Schwaben Augsburg on Fri 23-Dec-2024 Last updated on 23-Dec-2024 at 09:55 GMT International agricultural processor and merchant Louis Dreyfus Company (LDC) has signed a binding agreement to buy BASF’s Food and Health Performance Ingredients business. Headquartered in the Netherlands in Rotterdam, LDC serves more than 100 countries across 180 locations. This acquisition from BASF will see the company taking on board a production site and R&D centre in Illertissen, Germany, alongside three application labs outside of Germany. The food and health performance ingredients business includes food performance ingredients such as aeration and whipping agents, food emulsifiers and fat powder grades; health ingredients such as plant sterols esters, conjugated linoleic acid (CLA), omega-3 oils for human nutrition and some smaller product lines. BASF said its Food and Health Performance Ingredients portfolio plays a vital role in addressing growing trends in human nutrition. However, the business has limited synergies and integration into BASF and is no longer a strategic focus area. “Building on our teams’ success to develop this business very well over the last years, LDC as a future-oriented company can offer our employees and portfolio a promising perspective,” said Michael Heinz, member of the board of executive directors of BASF and responsible for the Nutrition & Health division. “The divestment of this business to LDC supports our strategic portfolio optimisation and will allow us to focus on our core businesses in Nutrition & Health. We remain committed to leveraging our core product platforms and expanding our business in key areas such as vitamins, carotenoids and feed enzymes.” Through the proposed acquisition, LDC aims to leverage its existing strengths in oils and fats, glycerin and lecithin, as well as its global supply chains, to reinforce its global position in nutritional and functional ingredients. “In line with our strategic plans for revenue diversification through more value-added products and growth in downstream markets, this agreement is an opportunity to accelerate LDC’s participation in the rapidly growing plant-based ingredients market,” added Michael Gelchie, LDC’s chief executive officer. As part of the agreement, approximately 300 employees are expected to transfer from BASF to LDC as of the closing of the transaction. “We are excited about the prospect of this transaction, as LDC’s first investment in dedicated facilities to produce food and health performance ingredients at scale,” Gelchie continued. The agreement is subject to regulatory approvals and customary closing conditions. NPD launches: Convenience and health20-Dec-2024Simplicity, function and health prove to be key themes in our latest round-up of new product launches. UK food and drink exports continue to spiral downwards20-Dec-2024By Bethan GryllsUK food and drink exports have fallen 10.2% to £16.3bn in the first nine months of 2024, driven by a sharp drop in alcohol sales. I'Anson Brothers completes £20m feed mill18-Dec-2024By Gwen RidlerNorth Yorkshire-based I’Anson Bros has completed construction of a new £20m animal feed mill, Waterloo House. Sharing innovation for net zero gainPaid for and content provided by European Union Why food and drink manufacturers need to embrace – rather than fear – artificial intelligencePaid for and in partnership with QAD Redzone From waste to worth: how F&B manufacturers can turn challenges into strategic winsPaid for and content provided by Biffa So much has changed since we were founded in 1849 But not our commitment to finding innovations that help people Cousins Charles Pfizer and Charles Erhart founded Charles Pfizer & Company in a red brick building in Brooklyn Pfizer buys and renovates a post-Revolutionary-era building at 81 Maiden Lane in Manhattan and moves its headquarters there The expansion propelled by the Civil War continues and Pfizer's revenues double The company now has a substantially increased product line and 150 new employees it buys and renovates a post-Revolutionary-era building at 81 Maiden Lane in Manhattan and moves its headquarters there The site carries the Pfizer name for nearly a century Spurred by America's westward expansion and its own growing number of clients west of the Mississippi Pfizer opens offices and a warehouse in Chicago Pfizer files an official certificate of incorporation in the state of New Jersey with authorized capital of $2 million divided into 20,000 shares of $100 each Pfizer would remain a privately held company until June 22 when 240,000 shares of new common stock were offered to the public Emile Pfizer was the last member of the Pfizer/Erhart family to be actively involved with the company is appointed President at a special board meeting He serves as President from 1906 to 1941 and briefly as Chairman in 1941 He is the last member of the Pfizer/Erhart family to be actively involved with the company Charles Pfizer dies while vacationing at his Newport A tribute to Pfizer in The New York Tribune notes that "by bringing to his task a thorough German technical education he successfully met all difficulties and each year expanded his business." Company sales exceed $3 million starting at Pfizer in 1873 as an office boy opened the company's first branch in Chicago within ten years The Board of Directors creates the position of Chairman and elects John Anderson to that post who had joined Pfizer in 1873 as a 16-year-old office boy Pfizer chemist James Currie and his assistant successfully pioneer the mass production of citric acid from sugar through mold fermentation—an achievement that eventually frees Pfizer from dependency on European citrus growers Kane goes on to develop a new deep-tank fermentation method using molasses rather than refined sugar as raw material—the process that will ultimately unlock the secret for large-scale production of penicillin He became vice president of the company in 1900 and served as Chairman of the Board from 1929 to 1940 John Anderson announces he is stepping down as chairman of the board Emile Pfizer continues to serve as president Doctor Richard Pasternack develops a fermentation-free method for producing ascorbic acid After building a new plant and initiating a 24-hour-a-day Pfizer becomes the world's leading producer of vitamin C Pfizer pushes ahead in 1938 with production of vitamin B-2 and eventually develops a vitamin mix that includes riboflavin Pfizer will become the established leader in the manufacture of vitamins Pfizer succeeds so well in the production of citric acid by fermenting sugar that a pound of citric acid and Pfizer is widely recognized as a leader in fermentation technology Pfizer responds to an appeal from the United States Government to expedite the manufacture of penicillin to treat Allied soldiers fighting in World War II Of the companies pursuing mass production of penicillin Pfizer's senior management invests millions of dollars putting their own assets as Pfizer stockholders at stake to buy the equipment and facilities needed for this novel process of deep-tank fermentation Pfizer purchases a nearby vacant ice plant and employees work around the clock to convert it and perfect the complex production process Pfizer is producing five times more penicillin than originally anticipated Penicillin is a turning point in human history—the first real defense against bacterial infection Pfizer is successful in its efforts to mass-produce penicillin and becomes the world's largest producer of the "miracle drug." Most of the penicillin that goes ashore with Allied forces on D-Day is made by Pfizer The company's contribution to the war effort is heralded nationwide and earns Pfizer the coveted Army-Navy "E" Award on April 17 Anderson becomes Pfizer's chairman of the board a broad-spectrum antibiotic that is the result of the Company's first discovery program becomes the first pharmaceutical sold in the United States under the Pfizer label Pfizer begins expansion into overseas markets and the International Division is created Terramycin also marks the beginning of the Pfizer Pharmaceutical Sales Force Upon its approval by the United States Food and Drug Administration on March 15 eight specially trained Pfizer pharmaceutical salesmen waiting for word at pay phones across the nation move into action to get inventory to wholesalers and to educate physicians about Pfizer's first proprietary pharmaceutical product These men are the vanguard of a sales and marketing organization that will come to be recognized as the best in the industry Pfizer operations are established in Belgium then assistant to Pfizer President John McKeen directs his international teams to “study the economy establish proper contacts with government officials and hire local employees wherever possible." While other companies keep their international employees on a short leash Pfizer gives its international people tremendous autonomy enabling them to make critical decisions immediately This formula proves to be remarkably successful in the years ahead Pfizer establishes an Agricultural Division dedicated to offering cutting-edge solutions to animal health problems The division opens its 700-acre farm and research facility in Terre Haute becomes a division of Pfizer. Roerig remains an integral part of Pfizer's outstanding marketing division laying the foundation for Pfizer's research and development operations in Great Britain Pfizer partners with Japan's Taito to manufacture and distribute antibiotics Pfizer acquires full ownership of Taito in 1983 New Pfizer pharmaceutical plants begin production in Mexico International personnel increases from 4,300 in 1957 to over 7,000 The Company signals its increasing commitment to research by consolidating its medical research laboratory operations in Groton Pfizer begins a decade of substantial growth and establishes new World Headquarters in midtown Manhattan President and Chief Executive Officer Chas when Powers assumes full leadership of the company the company's first once-a-day broad-spectrum antibiotic is introduced and quickly becomes a top seller Pfizer crosses the billion-dollar sales threshold Pfizer introduces Minipress® (prazosin HCI) in the United States Feldene® (piroxicam) becomes one of the largest-selling prescription anti-inflammatory medications in the world and Pfizer's first product to reach a total of a billion United States dollars in sales Pfizer introduces Unasyn® (ampicillin sulbactam) The Agricultural Division is renamed the Animal Health Division Pfizer launches Procardia® XL (nifedipine) extended-release tablets an innovative once-a-day medication for angina and hypertension is launched in the United States and 15 additional countries Originally approved for systemic fungal infections in 1994 it receives a new indication in the U.S The single-dose Diflucan® tablet is a welcome alternative to the existing treatments that requires topical applications of cream for a week or more His goal is to refocus the Company on its core competencies Pfizer has a triple rollout of major new medicines: Zoloft® (sertraline hydrochloride) for treatment of depression Norvasc® (amlodipine besylate) for control of angina and hypertension and Zithromax® (azithromycin) for respiratory and skin infections the industry's premier drug-donation program Sharing the Care provides medicines to more than one million eligible low-income and uninsured patients throughout the United States The Animal Health Division purchases SmithKline Beecham's animal health business making Pfizer a world leader in the development and production of pharmaceuticals for livestock and companion animals Pfizer increases its presence in the Far East by building a pharmaceutical plant in Dalian China and expanding throughout growing markets in the Pacific Rim Cardura® (doxazosin mesylate) is introduced in the United States for the treatment of benign prostate hyperplasia (BPH) Fortune® magazine names Pfizer the world's most admired pharmaceutical company Pfizer's roster of outstanding drugs grows with the launch of Viagra® (sildenafil citrate) a breakthrough treatment for erectile dysfunction Pfizer invests more than $3.3 billion in research and development Pfizer and the Edna McConnell Clark Foundation partner to establish the International Trachoma Initiative (ITI) to help eliminate blinding trachoma Learn more about Trachoma and the International Trachoma Initiative Pfizer celebrates its 150th anniversary as one of the world's premier pharmaceutical companies Recognized for its success in discovering and developing innovative drugs for human discovery Forbes® magazine names Pfizer "Company of the Year." Pfizer takes the drug discovery process to a new level of efficiency with the opening of the Discovery Technology Center in Cambridge Utilizing the emerging knowledge of gene families more efficient models for discovering drug candidates These candidates have an increased potential to survive the rigors of drug development Pfizer investment in research and development exceeds $4 billion for the first time Learn more about Pfizer's commitment to research The Best Get Better—Pfizer and Warner-Lambert merge to form the new Pfizer, creating the world's fastest-growing major pharmaceutical company. Learn more about the Pfizer/Warner-Lambert merger. Pfizer and the Ministry of Health of South Africa sign a Memorandum of Understanding to establish the Diflucan® Partnership Program Learn more about the Diflucan® Partnership Program Pfizer opens the largest building in the world dedicated to the discovery of new medicines for human and animal health on its Groton announces his retirement as CEO on January 1 and steps down as Chairman of the Board in April Hank McKinnell announces a new mission for Pfizer—to become the world's most valued company to patients and the communities where we work and live he announces a commitment to fund the building of a regional treatment and training center on the campus of Makerere University in Kampala Uganda as part of the Academic Alliance for AIDS Care and Prevention Pfizer launches Geodon® (ziprasidone hydrochloride) a new antipsychotic for the treatment of schizophrenia In a major expansion of its commitment to improving health care for low-income Americans Pfizer introduces The Pfizer For Living™ Share Card Program The program provides qualified low-income Medicare beneficiaries with access to up to a 30-day supply of any prescription medicine for a flat rate of $15 per prescription over half a million seniors enrolled in the program and nearly five million prescriptions were filled Pfizer invests an industry leading $5.1 billion in research and development and launches Vfend® (voriconazole) an orally and intravenously administered antifungal indicated for treatment of serious fungal infections pharmaceutical company and first top-ten company on the New York Stock Exchange to join the U.N an international network that promotes good corporate citizenship by fostering partnerships between companies The Pfizer Foundation announces the launch of a three-year initiative to provide grants to support training and capacity building for HIV/AIDS in developing countries Twelve organizations receive grants through the International HIV/AIDS Health Literacy Grants Program announces the Global Health Fellows program at the World AIDS Conference in Barcelona - a call to action for Pfizer colleagues to volunteer in developing countries for up to six months on HIV/AIDS projects the first eighteen Global Health Fellows are sent into the field Pfizer invests more than $7.1 billion in research and development On April 16, 2003 Pfizer Inc and Pharmacia Corporation combine operations, bringing together two of the world´s fastest-growing and most innovative companies. Learn more about the Pfizer/Pharmacia merger Pfizer Inc is selected by Dow Jones and Co to be included in the Dow Jones Industrial Average which is the best-known stock market barometer in the world Caduet® (amlodipine besylate and atorvastatin calcium) the first single pill that treats both high blood pressure and high cholesterol the pharmaceutical industry's most comprehensive prescription medicines access initiative is launched enabling America's 45 million uninsured to obtain Pfizer medicines free or at significant savings a new medical facility providing state of the art training and treatment of HIV/ADS and other infectious diseases opens its doors on the grounds of Makerere University in Kampala as part of a unique public-private partnership with a number of organizations contribute more than $15 million to support construction of the building Food and Drug Administration to treat two distinct forms of neuropathic pain associated with diabetic peripheral neuropathy (DPN) postherpetic neuralgia (PHN) and adjunctive treatment of partial onset seizures in adults with epilepsy Pfizer's roster of outstanding drugs grows with the launch of Sutent® (sunitinib malate) multikinase inhibitor to treat patients with metastatic renal cell carcinoma (mRCC) and gastrointestinal stromal tumor (GIST) after disease progression on a new medicine to treat certain infections caused by Candida a yeast-like fungus that can cause serious infections in hospitalized patients or patients with compromised immune systems a prescription medicine to help adults stop smoking the Pfizer Board of Directors names Jeffrey B who will remain Chairman of the Board until his retirement in February Pfizer launches Selzentry™ (maraviroc) tablets the first in a new class of oral HIV medicines in more than 10 years Selzentry blocks viral entry into white blood cells significantly reducing viral load and increasing T-cell counts in treatment-experienced patients infected with a specific type of HIV Pfizer launches an online site to provide up-to-date user-friendly information on the status of its U.S post-marketing commitments - studies conducted after a medicine receives regulatory approval and designed to provide additional information about the medicine's safety This initiative is the first of its kind for a pharmaceutical company To help address critical gaps in malaria treatment and education Pfizer announces the launch of Mobilize Against Malaria announces the next step in the company's evolution and outlines the company's plan to establish smaller operating units designed to enhance innovation and accountability while drawing upon the advantages of Pfizer's scale and resources These customer-focused business units allow Pfizer to better anticipate and respond to customers' and patients' needs as well responds to changes in the marketplace Pfizer launches a new Medicine Safety Website to help healthcare professionals and patients make better informed decisions about treatment options the pioneering micro-financing organization in Bangladesh that shared the Nobel Peace Prize in 2006 for its work to alleviate poverty partners with Pfizer to identify sustainable models for healthcare delivery in the developing world Pfizer launches its Global Regenerative Medicine Unit The unit is dedicated to understanding the biology of stem cells and the opportunity these cells provide to discover and develop a new generation of regenerative medicines that may prevent disability repair failing organs and treat degenerative diseases Pfizer enters into an agreement with Medivation to develop and commercialize an investigational medicine for treating Alzheimer's disease and Huntington's disease creating a company with a broad range of products and therapies that touch the lives of patients and consumers every day and at every stage of life Pfizer launches Toviaz (fesoterodine fumarate) a prescription medicine used in adults to treat symptoms of a condition called overactive bladder Pfizer enters into major licensing agreements with two Indian-based pharmaceutical companies — Claris Lifesciences Ltd. and Aurobindo Pharma Ltd. — to enhance medicinal availability to underserved populations around the world and add new non-Pfizer medicines to the company's existing portfolio of established products Because patient participation in clinical trials is the key to progress in medical research Pfizer enters into a collaboration with Private Access an innovator in privacy-enhanced search technology to create a new online community aimed at increasing clinical trial awareness and participation Ian Read joins Pfizer as Chief Executive Officer he served as Senior Vice President and Group President of the Worldwide Biopharmaceutical Businesses which he led from 2006 through December 2010 he oversaw five global business units—Primary Care Read began his career with Pfizer in 1978 as an operational auditor holding positions including Chief Financial Officer Pfizer announces a diversified R&D platform named Pfizer Worldwide Research and Development large molecules and vaccine research and development Pfizer Completes Sale of Capsugel Business to KKR Pfizer announces that it has completed the sale of its Capsugel business to an affiliate of Kohlberg Kravis Roberts & Co following the receipt of required regulatory clearances files a registration statement with the U.S Securities and Exchange Commission for a potential initial public offering (IPO) of Class A common stock The offering is expected to represent an ownership stake of up to 20 percent which is targeted for the first half of 2013 Pfizer will transfer its animal health business to Zoetis Pfizer announces plans to move forward to internally separate its commercial operations into three business segments two of which will include Innovative business lines and a third which will include the Value business line Each of the three segments will include developed markets and emerging markets The changes are implemented in January 2014 in countries that do not require a consultation with works councils or unions and are then implemented in countries that require consultation after the successful conclusion of those processes Pfizer announces that it has entered into a definitive agreement to acquire Baxter International Inc.’s portfolio of marketed vaccines for $635 million Pfizer will also acquire a portion of Baxter’s facility in Orth Pfizer announces that they have entered into a definitive merger agreement under which Pfizer will acquire Hospira This strategically complementary combination adds a growing revenue stream and a platform for growth for Pfizer’s GEP business The expanded portfolio of sterile injectable pharmaceuticals composed of Hospira’s broad generic sterile injectables product line including acute care and oncology injectables with a number of differentiated presentations combined with GEP’s branded sterile injectables will create a leading global sterile injectables business The combination also reinforces GEP’s growth strategy to build a broad portfolio of biosimilars in Pfizer’s therapeutic areas of strength through the addition of Hospira’s portfolio that includes several marketed biosimilars Pfizer will also use its existing commercial capabilities scientific expertise and world class development capabilities to significantly expand the reach of Hospira’s products which are currently distributed primarily in the United States Watson Health and Pfizer announce a collaboration that will utilize IBM Watson for Drug Discovery to help accelerate Pfizer's research in immuno-oncology an approach to cancer treatment that uses the body's immune system to help fight cancer Pfizer is one of the first organizations worldwide to deploy Watson for Drug Discovery and the first to customize the cloud-based cognitive tool – tapping in to Watson's machine learning and other cognitive reasoning technologies to support the identification of new drug targets and patient selection strategies in immuno-oncology which modify a patient's immune system to recognize and target cancer cells using a combination of vaccines Oncology researchers at Pfizer will use Watson for Drug Discovery to analyze massive volumes of disparate data sources including licensed and publicly available data as well as Pfizer's proprietary data Pfizer researchers will analyze and test hypotheses to generate evidence-based insights for real-time interaction The customized technology can also support efficient safety assessments Pfizer and Corning Incorporated announce collaborations that have enabled the modernization of pharmaceutical packaging with the introduction of Corning Valor™ Glass This revolutionary pharmaceutical glass packaging solution enhances the storage and delivery of today’s drug formulations and provides more reliable access to medicines essential to public health Deep pharmaceutical formulation and manufacturing process insights from Merck and Pfizer in combination with Corning’s glass science and precision forming capabilities helped deliver an exceptional glass packaging solution for injectable drugs in vials and cartridges The companies’ continued collaborations will focus on additional evaluations and the deployment of this new innovation Corning Valor Glass packaging offers superior chemical durability These qualities enable increased throughput and more reliable access to state-of-the-art medicines for patients while maintaining a high level of quality assurance for pharmaceutical companies Pfizer leads the world in developing a vaccine and treatment in response to the COVID-19 pandemic and commits to lightspeed manufacturing to expand vaccine and treatment access to people around the world Pfizer is committed to providing shareholders and the public with a transparent view of our efforts toward fulfilling our purpose: Breakthroughs that change patients’ lives our annual reports detail the strategic development We innovate every day to make the world a healthier place It was Charles Pfizer’s vision at the beginning and it holds true today.  Incredible things can happen when people come together with one shared goal The future of medicine is happening at Pfizer and we’re eager to work alongside inspired and inspirational people who want to make things better.Incredible things can happen when people come together with one shared goal and we’re eager to work alongside inspired and inspirational people who want to improve health around the world.  The qualities you demonstrated as a member of the armed forces are most welcome at Pfizer We’re turning advanced science and technologies into therapies that matter most and your efforts could impact millions of people.  we’re committed to increasing diversity and fostering inclusivity in this first-of-its-kind Our ambitions are big and our product pipeline has never been stronger We’re energized and inspired to apply science and our global resources to develop and deliver breakthrough therapies to people everywhere This information—including product information—is intended only for residents of the United States The products discussed herein may have different labeling in different countries It was a double whammy for professional dressage rider Lisa Horler in the Bundeschampionate qualification classes held at the Illertissen dressage fresival on 5 - 6 June 2021 She won the 5-year old division with Define Dynamic and the 6-year old class with Danny Cool Thirteen combinations competed in the 5-year old division Lisa Horler steered Margit Esiner's DSP stallion Define Dynamic (by Danciano de Malleret x Samarant) to a high score of 8.8 for the win 8.5 for submission and 9 for general impression Austrian Christian Lanterdinger and Jutta Steidl's Hanoverian gelding Bassantino (by Benicio x Furst Romancier) tied in second place on 8.0 with Katrin Burger aboard Edwin Schuster's DSP gelding Bocaccio (by Bon Coeur x Carpaccio) The liver chestnut Bassantino received 7.5 for walk 8.5 for canter and 8 for submission and general impression while Bocaccio got identical marks for all five components Lisa Horler also bested the field of 12 in the 6-year old division this time piloting Margit Esiner's DSP bred gelding Danny Cool (by Danciano de Malleret x Sandro Hit) They achieved the highest qualification score of the season The dark bay gelding got 9 for walk and canter 10 for submission and 9.5 for general impression Austrian Heinz-Jörg Wächter and Eberhard Maurer's Oldenburg stallion Furst Finest (by Finest x Hotline) followed in second place with a strong 8.7 total score 8 for submission and 9 for general impression Photo © Rainer Dill Stalls for Rent at Durondeau Dressage in Peer, Belgium Exceptionally Well Located Equestrian Facility in Wellington, Florida Well-built Equestrian Estate With Multiple Business Opportunities in Sweden Stable Units for Rent at Lotje Schoots' Equestrian Center in Houten (NED) For Rent: Several Apartments and Stable Wing at High-End Equestrian Facility Stable Wing Available at Reiterhof Wensing on Dutch/German border Real Estate: Well-Appointed Country House with Extensive Equestrian Facility in the U.K. Rémi Blot 29 Mar 2025 13:00:00 GMT?.css-1txiau5-AnswerContainer{color:var(--GlobalColorScheme-Text-secondaryText2);}Türkgücü München vs FV Illertissen on Sat The current head to head record for the teams are Türkgücü München 3 win(s) Türkgücü München and FV Illertissen have not drawn any of their last 3 matches against each other Have scored 4 goals in their last 5 matches Haven't scored in their last 2 matches Who won between Türkgücü München and FV Illertissen on Sat 29 Mar 2025 13:00:00 GMT?Türkgücü München vs FV Illertissen on Sat 29 Mar 2025 13:00:00 GMT ended in a 2–2 tie.InsightsHave scored 7 goals in their last 5 matches Türkgücü München is playing home against FV Illertissen on Sat Bernhard Reiser was born in 1966 in Illertissen he discovered his passion for cooking thanks to his grandmother who owned a fruit and vegetable shop in town and could create delicacies from any ingredient he began his career as a chef at the officers' casino in Lagerlechfeld He then worked as a chef de partie and sous-chef at the "Romantik Hotel Augsburger Hof." In 1993 he became head chef at "Schloss Solitude" in Stuttgart and head chef at "Bosshotel" in Metzingen he served as a culinary consultant for Hänisch Castle and city hotels in Solitude preparing state banquets for personalities like Boris Eltsin he opened the restaurant "Louvre" in Rothenburg ob der Tauber which received a MICHELIN Star from 1996 until its closure in 2003.In May 2002 he opened the "Weinstein Restaurant Weinbar" in Würzburg later renamed "Reisers am Stein." From January 2008 the restaurant started exclusively offering smaller portions following the motto "Farewell to the main course," with Bernhard's wife the restaurant was awarded a MICHELIN Star Bernhard Reiser has explored various culinary traditions He teaches the "Food Management" course at DHBW Mosbach "Reisers Kochschule," he also promotes the healthy aspect of food.In February 2010 Bernhard was honored with the Warsteiner Prize he became the nutritional consultant for the German women's national football team Bernhard has hosted his culinary program called "Ask the Reiser." he is active not only as a chef and restaurateur but also as a researcher and entrepreneur He collaborates with Maison Krug and manages "REISERS Zehnthof," listed in the MICHELIN Guide "REISERS Kochwerkstatt & Catering," and "Aifach REISER am Marktplatz." Do you want to discover the latest news and recipes of the most renowned chefs and restaurants in the world La nostra società utilizza inoltre cookie funzionali per registrare informazioni sulle scelte dell’utente e per consentire una personalizzazione del Sito; ad esempio Questi cookie possono essere installati dalla nostra società o da Terze parti In caso di disabilitazione di questi cookie la qualità e l’esperienza di navigazione potrebbe non essere soddisfacente Questi cookie sono installati da social media per consentire la condivisione dei contenuti del presente Sito Essi sono in grado di monitorare la navigazione compiuta anche in altri siti e creano un profilo dell’utente sulla base dei suoi interessi Ciò potrebbe avere un impatto sul contenuto e messaggi visualizzati sugli altri siti visitati non sarà possibile utilizzare o visualizzare questi strumenti di condivisione per l’installazione e l’uso di tali cookie occorre il consenso dell’utente Per maggiori informazioni consulta la pagna cookies policy don't miss a thing: Our newsletter for the chemical industry lab technology and process engineering brings you up to date every Tuesday and Thursday product highlights and innovations - compact and easy to understand in your inbox The function "Store search" is only available to registered users The citral plant at BASF's site in Ludwigshafen provides the key building block for BASF's fine chemicals: Citral is a starting material for vitamins A and E as well as for carotenoids and a variety of aroma chemicals BASF completed an investment in a vitamin A plant expansion in Ludwigshafen Germany to enhance vitamin A supply and will now expand its world-scale vitamin A formulation plant for animal nutrition with start-up scheduled in mid-2023 BASF has expanded the production capacity of its feed enzymes plant in Ludwigshafen which will further support the growth plans of customers in the animal nutrition industry the organization will be further developed to support growth opportunities and investments address sustainability trends and leverage proximity to growth markets  “We have a leading position as a strong partner in nutrition We need to evolve by tailoring our business portfolio with growth investments into our core value chains technology and R&D capabilities to meet sustainability needs and address the challenges of climate change,” said Anup Kothari The new Nutrition Ingredients global business unit based in Germany will build on large-scale product platforms supported by the division’s technology leadership and will be led by Senior Vice President Julia Raquet BASF will continue to serve its customers in animal nutrition and human nutrition with dedicated teams feed enzymes will focus on high-quality ingredients to support animal nutrition customers in maximizing the nutritional value of feed BASF’s food and health performance ingredients portfolio which is produced at the company’s site in Illertissen plays a vital role in addressing growing trends in human nutrition the business has limited portfolio synergies and integration into the BASF Verbund strategic options will be evaluated to identify suitable opportunities for this business The evaluation will not impact BASF’s food and health performance ingredients production in Illertissen supply abilities or commitments to customers To meet the growing demands of the flavor and fragrance industry BASF will further develop the organization for Aroma Ingredients into a global business unit led by Senior Vice President Thilo Bischoff The Aroma Ingredients unit will be headquartered in Singapore This will ensure proximity of the Aroma Ingredients headquarters to major growth markets in Asia while fully maintaining the strong commitment and connection to markets in the other regions Pharma Solutions will continue to be based in the United States and be led by Senior Vice President Jeffrey DeAlmeida BASF will support customers in developing effective and reliable formulations with high-quality biopharmaceuticals active ingredients and tailored digital solutions DePoly to launch 500-tonne-per-year showcase plant Novel spectral filters will enable future sensors to work more accurately and reliably “Start-ups provide crucial impulses for the future of our industry” Start-up portrait: Lactips - Natural revolution against microplastics in the industry Focus on climate-neutral production: 39% CO₂ reduction already achieved in Scope 1 and Scope 2 New report presents policy proposals for a Renewable Carbon Future Over 60 million euros for the recycling of battery black mass Reducing the environmental impact of the chemical and coffee industry: OHAUS as partner Green transformation remains one of the top management priorities alongside digitalization and AI Forestal will utilize BASF's proprietary OASE® technology for efficient CO2 removal in the production of e-methanol Four Universities and Futury Launch the Future Factory Interview with ICODOS on e-methanol production for climate-neutral industries Very interesting class of materials for electrocatalysts discovered? Scientists succeed in fully synthesizing one of the strongest natural cytotoxic substances: a great step forward for cancer research New tool turns complex process of simulating molecules in solution into a user-friendly chat TU Graz and start-up BRAVE Analytics have developed a method for detecting nanoplastics in liquids and determining their composition A third generation of biodegradable plastics could bring hope in the fight against plastic waste Investment of CAD$150 million (ca. €97 million) over five years This research offers a potential way to repair teeth and a natural dental treatment alternative Unilever announced it has reached a new arrangement for Ben & Jerry’s in Israel which will ensure the ice cream stays available to all consumers New mathematical model demonstrates ratio of potassium to sodium intake key to regulating blood pressure US laboratory market with top growth forecasts Start-up portrait: QuantiLight revolutionizes blood tests with home monitoring platform AI-driven biotech research: Connected labs for faster scientific progress Research team shows very precise and comprehensive correlation between immune profiles and age, gender, smoking, obesity and diseases Mushroom study expands knowledge of natural bitter compounds New insights into the brain’s default mode network Results in seconds rather than hours: Groundbreaking instrument-free assay nears completion Researchers decipher novel mode of action of natural product antibiotic New research finds mangos may be key to reducing insulin resistance in adults who are overweight or obese Interdisciplinary research approach enables breakthrough "Nature" publication reveals the evolutionary link between two fundamental biological processes NYU Tandon researchers develop technology to calculate calories and nutrients from food images This could lead to a much more compact design of quantum sensors New approach could potentially mark a turning point in the antibiotics crisis ProVeg speaks of "intermediate plateau" and underlines call for a future nutrition plan Visualization of molecular structures with unprecedented detail Alzheimer's research: New in vitro laboratory study provides important insights Early detection of strokes and heart attacks It is a detailed view of the brain like never seen before: allowing users to zoom in and out — from all angles, like a Google Earth map Great sustainability ambitions and willingness to innovate despite the need to save money From now on, don't miss a thing: Our newsletter for chemistry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. © 1997-2025 LUMITOS AG, All rights reserved 11 Apr 2025 17:00:00 GMT?.css-1txiau5-AnswerContainer{color:var(--GlobalColorScheme-Text-secondaryText2);}TSV Schwaben Augsburg vs Türkgücü München on Fri The current head to head record for the teams are TSV Schwaben Augsburg 1 win(s) Have scored 9 goals in their last 5 matches Who won between TSV Schwaben Augsburg and Türkgücü München on Fri 11 Apr 2025 17:00:00 GMT?TSV Schwaben Augsburg vs Türkgücü München on Fri 11 Apr 2025 17:00:00 GMT ended in a 1–1 tie.InsightsHave scored 8 goals in their last 5 matches TSV Schwaben Augsburg is playing home against Türkgücü München on Fri 26 Apr 2025 12:00:00 GMT?.css-1txiau5-AnswerContainer{color:var(--GlobalColorScheme-Text-secondaryText2);}Nürnberg II won 2–0 over FV Illertissen on Sat The current head to head record for the teams are Nürnberg II 12 win(s) Haven't kept a clean sheet in 5 matches Nürnberg II and FV Illertissen have not drawn any of their last 3 matches against each other Have scored 7 goals in their last 5 matches Who won between Nürnberg II and FV Illertissen on Sat 26 Apr 2025 12:00:00 GMT?Nürnberg II won 2–0 over FV Illertissen on Sat 26 Apr 2025 12:00:00 GMT.InsightsHave scored 10 goals in their last 5 matches Nürnberg II is playing home against FV Illertissen on Sat 11 Apr 2025 17:00:00 GMT?.css-1txiau5-AnswerContainer{color:var(--GlobalColorScheme-Text-secondaryText2);}Burghausen vs FV Illertissen on Fri The current head to head record for the teams are Burghausen 6 win(s) Who won between Burghausen and FV Illertissen on Fri 11 Apr 2025 17:00:00 GMT?Burghausen vs FV Illertissen on Fri 11 Apr 2025 17:00:00 GMT ended in a 1–1 tie.InsightsHave scored 10 goals in their last 5 matches Burghausen is playing home against FV Illertissen on Fri SALT LAKE CITY — Corbin McMillen liked hiking in Zion National Park and its most infamous trail – the summit to Angels Landing “I think he liked Angels Landing,” said Margie Barron “because it was… it gave him some adrenaline.” Thirteen hikers have fallen and died from Angels Landing, or the trail to it, since 2000, according to records compiled by FOX 13. The tally includes two Utah men who have died in the last month Yet the trail remains open to anyone who passes through Zion’s gates No permits or special instruction is required “If it’s not the most dangerous trail in America, it’s one of the top five,” said Travis Heggie, an associate professor at Bowling Green State University who studies deaths in the national park system He also used to work in risk management for the National Park Service the trail to Angels Landing isn’t that long or steep Most hikers take a route that’s a 5-mile roundtrip with a 1,500-foot elevation gain The highlight is the Angels Landing – an overlook with views of the park’s red rock pillars and the peaks and valleys of southwest Utah “Angels Landing is one of those ‘Bucket List’ hikes that folks want to do,” said Jeff Rose a professor of outdoor recreation studies at the University of Utah About the last third of the trail has steep drops on the sides You’re climbing over some difficult rock.” FOX 13 obtained death investigation reports from the National Park Service and the Washington County Sheriff’s Office and shared them with Heggie and Rose The trail’s best-known stretch is a narrow section where the park service has installed a chain handrail “Folks were falling either before the chained section or after the chained section,” Rose said who noted some hikers fell from Angels Landing itself He said the data indicates hikers are getting too close to the edges. Rose pointed to an investigation report from 2010 where witnesses said a woman had been seated on the edge of the trail. She stood then fell over the edge, witnesses told rangers “Don’t get within 6 feet of the edge where you can fall and potentially lose life and limb,” Rose said Heggie noticed many of the people who fell where hiking alone or, like a 13-year-old girl from Colorado City, Arizona, who died in 2018 Heggie suggests people hike in groups of three or more and stay together “Don’t leave children alone on that trail,” Heggie said Of the thirteen people who have fallen to their deaths from Angels Landing since 2000, most were men, and most were visiting from outside Utah, including one man from Germany. Visitation to Zion National Park has doubled over the past 30 years, reaching almost 4.5 million people in 2019 This most-recent January and February set visit records One fatality report from 2017 noted the trail was averaging 641 visitors per day Yet Rose and Heggie didn’t find evidence the crowding itself caused any falls There were no reports of anyone being elbowed off the trail Despite that, Heggie favors limiting access to the trail through a permitting system. Zion already has a permit and lottery system for the Subway “Because there’s way too many people getting on this [Angels Landing] trail,” Heggie said “and there’s way too many inexperienced people getting on this trail.” “is liable for a lot of these incidents that happen on the park in light that they are aware of the risks.” When asked why not close the Angels Landing trail altogether Heggie replied: “I have no problem with that.” Representatives of the National Park Service did not answer questions from FOX 13 He sees a permitting system as an option that might have to be tried though he warns doing so might increase traffic elsewhere in the park First, Rose wants the park service to increase the education of hikers pondering a trek to Angels Landing. The park service already warns on Zion’s website and in signage at the trailhead that the hike’s steep drops have killed people. One thing Rose doesn’t want is more railings on the trail. He says that would detract from the natural setting. “One of the reasons that we appreciate these spaces,” Rose said, “is because they allow a chance of contemplative leisure where we can think about bigger issues – bigger than ourselves or bigger than society and things like that.” Barron would like rangers on the trail who can enforce safety rules and keep an eye on hikers. She wonders if such a ranger could have watched out for her son. McMillen moved to southern Utah three years ago to help his father, who is in hospice care. Barron said on days when nursing aids would provide extra assistance, McMillen would use the opportunity to go hiking. On Feb. 19, when the aids came to the house, Barron and McMillen exchanged I love you. Barron also told her 42-year-old son to be careful. Barron thinks McMillen had already reached Angels Landing and was on the return. She’s been told by park staff and sheriff’s investigators that her son had left the trail, perhaps to look around. McMillen didn’t take his coat with him. His mother wonders if he developed hypothermia and got disoriented. No one saw McMillen fall. Barron reported her son missing that night. A search began the next morning. “They called and said we’ve located him and identified him,” Barron said. “I started wailing, and said ‘Oh, my boy. My boy.’” After his memorial service, McMillen’s family gathered for a photo underneath the spot on the trail where he fell. “I didn’t know until my son passed how many people have died at Angels Landing,” Barron said. Angels Landing fall deaths since 2000, according to records compiled by FOX 13: 29 Mar 2025 13:00:00 GMT?.css-1txiau5-AnswerContainer{color:var(--GlobalColorScheme-Text-secondaryText2);}Ansbach vs Eintracht Bamberg on Sat The current head to head record for the teams are Ansbach 2 win(s) Have scored 1 goals in their last 5 matches Who won between Ansbach and Eintracht Bamberg on Sat 29 Mar 2025 13:00:00 GMT?Ansbach vs Eintracht Bamberg on Sat 29 Mar 2025 13:00:00 GMT ended in a 1–1 tie.InsightsHave scored 11 goals in their last 5 matches Ansbach is playing home against Eintracht Bamberg on Sat Registration has been successfully completed Make a new account if you don't have one yet Puedes ver la versión Española de BeSoccer.com You can see the English version of BeSoccer.com Vous pouvez voir la version French de BeSoccer.com Puoi vedere la versione Italian su BeSoccer.com Você pode ver a versão Brasileira de BeSoccer.com Sign up for our daily Newsletter and stay up to date with all the latest news You are receiving this pop-up because this is the first time you are visiting our site You are using software which is blocking our advertisements (adblocker) we are relying on revenues from our banners So please disable your adblocker and reload the page to continue using this site.Thanks every retailer tries to stand out from the crowd with certain specialities and exclusive products Franz Laslo from Schorndorf is no exception: the committed retailer has been operating a shop under the name "Beit Shalom" (House of Peace) for almost 15 years This shop offers its customers a rich selection of Israeli products of all kinds he has increasingly devoted himself to the sale of fresh and dried fruit from Israel And the success is there: soon he will open a third branch in Wanfried Franz Laslo and his wife were involved in various projects in Israel from 1979 to 1987 the desire grew to open an independent business with Israeli and 'oriental' products the first commercial shop was opened in Schondorf in 2005 our company and our product range have grown steadily After the first business years we started to offer the first fruits from Israel - at that time with only 30 boxes of oranges because last year we had a total fruit sales of about 12 tons Although we can supply some fruit products all year round the focus of our marketing season is still on winter only fruit sales currently account for around one third of our total annual sales." Sharmuti oranges still the best sellerAs far as the products from his second home are concerned he believes that the great citrus boom in Israel is now over the fruits are still available and some customers are actively looking for them The Orri-Clementine is still very important Grapefruit is also enjoying increasing demand especially the red fleshed ones."  Laslo also sees an interesting market potential for the so-called sweetie a green citrus fruit or a cross between grapefruit and grapefruit "It is not as bitter as a white grapefruit and is already available on the market which are suitable both for direct consumption and for the juice press the already established Orri-Clementine arrives on the market one of the most popular Israeli citrus fruits of all time which arrived for the first time just before Christmas a few years ago but are now only available in the New Year Navel oranges have almost disappeared from the market There are also juice oranges from Israeli cultivation which is our bestseller in terms of quantity Half of our total turnover last year was Sharmuti oranges" the specialist retailer's range also includes pomegranates "We are currently looking for dried figs from Israel." FreshPublishers © 2005-2025 FreshPlaza.com 01 Mar 2025 13:00:00 GMT?.css-1txiau5-AnswerContainer{color:var(--GlobalColorScheme-Text-secondaryText2);}Würzburger Kickers won 2–0 over Bayern München II on Sat The current head to head record for the teams are Bayern München II 5 win(s) Who won between Bayern München II and Würzburger Kickers on Sat 01 Mar 2025 13:00:00 GMT?Würzburger Kickers won 2–0 over Bayern München II on Sat 01 Mar 2025 13:00:00 GMT.InsightsHave scored 10 goals in their last 5 matches Bayern München II is playing home against Würzburger Kickers on Sat Manchester, United Kingdom, April 21, 2022 (AFP) - Erik Ten Hag has never shied away from a challenge, but the biggest task of the Dutchman's coaching career awaits after accepting the role of Manchester United manager. Ten Hag, 52, will leave Ajax at the end of the season having restored their pride at the top table of European football in the Champions League and dominated domestically in his four years in charge. Performing a similar turnaround in United's fortunes after nearly a decade in the doldrums will be a higher mountain to scale. But Ten Hag boasts an unblemished managerial record from his unconventional route to one of the sport's most prized jobs. An unremarkable playing career included three spells at FC Twente, where he won his only major trophy as captain in the 2001 Dutch Cup. It was at Twente where his journey as a coach began too, working alongside former United assistant and England manager Steve McLaren. "I thought I knew football before, but going there and experiencing that... I knew nothing about football," McLaren told The Athletic of his experience with Ten Hag. "I have to sit up in the stands to see the patterns of a game, but he could stand on the touchline (and see them). He always knew the answer to everything, how to change shape, change positions." In his first role as a manager in his own right, Ten Hag got Go Ahead Eagles promoted to the top-flight of Dutch football. Yet, instead of testing himself in the Eredivisie, he took the bold decision to take over Bayern Munich's reserve side in the fourth-tier of German football. His two years in Munich coincided with Pep Guardiola's time as boss at Bayern with Ten Hag keen to soak up as much knowledge as he could from the Manchester City manager and the culture of working for a European giant. "During my time at Bayern Munich, among other things, I saw how things work (at a big club)," Ten Hag said reflecting on his time in Germany. "Every detail can be picked out for analysis. The media, people in general, always find something if you look for it. A hundred things can go right, if one thing goes wrong, people highlight it." That level of scrutiny is now what he will have to get used to and a club where plenty has gone wrong in recent years. Despite boasting one of the largest wage bills in world football, United have not won a trophy for five years. Barring an unlikely resurrection in the final weeks they will not even by playing in the Champions League next season. The more storied names of Louis Van Gaal and Jose Mourinho are among the five managers to have come and gone at Old Trafford since Alex Ferguson's retirement in 2013 sent the club into a spiral. Ten Hag will have to succeed where they failed while going up against an array of the world's best coaches in the Premier League such as Guardiola, Jurgen Klopp, Thomas Tuchel and Antonio Conte. But he could also be the right man at the right time for a long-needed cultural reset at United. Money has been thrown at their problems in the transfer market for many years to no avail. Cristiano Ronaldo's return in August was designed to help a star-studded squad mount a title challenge this season, but they are instead 23 points behind Manchester City. After a productive spell back in the Netherlands with Utrecht, Ten Hag has continued the Ajax tradition of using the club's academy as a sustainable model for success. Frenkie De Jong, Matthijs De Ligt and Donny Van de Beek were stars of the side that reached the Champions League semi-finals in 2019 before being sold on. A newly-assembled squad won all six Champions League group stage games this season, including thrashings of Borussia Dortmund and Sporting Lisbon. United's greatest days under Ferguson were built upon a mix of forming their own players and improving the imports they did splash out on. Ten Hag has to recover that lost trait as the starting point on a long road back to challenging for major honours. 02 Mar 2025 13:00:00 GMT?.css-1txiau5-AnswerContainer{color:var(--GlobalColorScheme-Text-secondaryText2);}Nürnberg II vs DJK Vilzing on Sun The current head to head record for the teams are Nürnberg II 2 win(s) Have scored 5 goals in their last 5 matches DJK Vilzing have won the previous 3 matches against Nürnberg II Who won between Nürnberg II and DJK Vilzing on Sun 02 Mar 2025 13:00:00 GMT?Nürnberg II vs DJK Vilzing on Sun 02 Mar 2025 13:00:00 GMT ended in a 1–1 tie.InsightsHave scored 8 goals in their last 5 matches Nürnberg II is playing home against DJK Vilzing on Sun Engineering Future Relevance – with Data & AI PwC won the sell-side mandate thanks to the long-standing excellent relationship with Pfizer Inc., for which we have been carrying out a series of divestitures of pharmaceutical manufacturing sites throughout Europe in recent years. PwC ran a highly competitive process involving both national and international financial and strategic bidders. R-Pharm eventually prevailed as the final bidder after intensive negotiations with Pfizer, for which Illertissen will continue to manufacture a series of products for a defined period. Founded in 1849, Pfizer Inc. is a multinational pharmaceutical conglomerate headquartered in New York, USA, with revenues of ~USD 50bn in 2013. Its product portfolio includes human biologic and small molecule medicines and vaccines as well as a wide range of consumer products. The Illertissen site was founded in the 1860s and had been acquired by Pfizer in 1971. The state-of-the-art production site employs nearly 400 professionals. It is leading in high containment manufacturing and equipped with highly automated packaging operations. It is specialized in oral solid dosage forms and equipped to deal with complex SKU profiles and large batch sizes. Founded in 2001 in Moscow, R-Pharm is a leading Russian pharmaceutical enterprise employing 2,800 professionals in 41 branches across Russian and the CIS countries. R-Pharm realized a turn-over of USD 1,5bn in 2013. Its services portfolio includes the manufacturing of finished drugs and APIs, R&D activities and the cooperation with major international pharmaceutical companies and universities in the field of drug development and combined clinical trials. Partner, Corporate Finance | M&A Healthcare & Consumer, PwC Germany 11 Apr 2025 17:00:00 GMT?.css-1txiau5-AnswerContainer{color:var(--GlobalColorScheme-Text-secondaryText2);}Bayern München II won 6–0 over Eintracht Bamberg on Fri The current head to head record for the teams are Bayern München II 6 win(s) Haven't kept a clean sheet in 8 matches Who won between Bayern München II and Eintracht Bamberg on Fri 11 Apr 2025 17:00:00 GMT?Bayern München II won 6–0 over Eintracht Bamberg on Fri 11 Apr 2025 17:00:00 GMT.InsightsHave scored 4 goals in their last 5 matches Bayern München II is playing home against Eintracht Bamberg on Fri 01 Apr 2025 15:45:00 GMT?.css-1txiau5-AnswerContainer{color:var(--GlobalColorScheme-Text-secondaryText2);}Türkgücü München won 2–0 over SpVgg Hankofen-Hailing on Tue The current head to head record for the teams are SpVgg Hankofen-Hailing 0 win(s) Who won between SpVgg Hankofen-Hailing and Türkgücü München on Tue 01 Apr 2025 15:45:00 GMT?Türkgücü München won 2–0 over SpVgg Hankofen-Hailing on Tue 01 Apr 2025 15:45:00 GMT.InsightsHave scored 6 goals in their last 5 matches SpVgg Hankofen-Hailing is playing home against Türkgücü München on Tue 12 Apr 2025 12:00:00 GMT?.css-1txiau5-AnswerContainer{color:var(--GlobalColorScheme-Text-secondaryText2);}Ansbach vs Greuther Fürth II on Sat Have scored 12 goals in their last 5 matches Who won between Ansbach and Greuther Fürth II on Sat 12 Apr 2025 12:00:00 GMT?Ansbach vs Greuther Fürth II on Sat 12 Apr 2025 12:00:00 GMT ended in a 0–0 tie.InsightsHave scored 9 goals in their last 5 matches Ansbach is playing home against Greuther Fürth II on Sat 17 Apr 2025 17:00:00 GMT?.css-1txiau5-AnswerContainer{color:var(--GlobalColorScheme-Text-secondaryText2);}Bayern München II won 2–1 over FC Schweinfurt on Thu The current head to head record for the teams are FC Schweinfurt 3 win(s) FC Schweinfurt and Bayern München II have not drawn any of their last 7 matches against each other Have scored 10 goals in their last 5 matches Who won between FC Schweinfurt and Bayern München II on Thu 17 Apr 2025 17:00:00 GMT?Bayern München II won 2–1 over FC Schweinfurt on Thu 17 Apr 2025 17:00:00 GMT.InsightsHave scored 10 goals in their last 5 matches FC Schweinfurt is playing home against Bayern München II on Thu The page you requested is temporarily unavailable